DHA
Dha is a lipid of Fatty Acyls (FA) class. Dha is associated with abnormalities such as Atherosclerosis, Consumption-archaic term for TB, Chronic disease, Cardiovascular Diseases and Diabetes Mellitus, Non-Insulin-Dependent. The involved functions are known as Inflammation, Oxidation, fatty acid oxidation, Fatty Acid Metabolism and Lipid Metabolism. Dha often locates in Hepatic, Protoplasm, Mucous Membrane, Epithelium and outer membrane. The associated genes with DHA are IMPACT gene, FATE1 gene, GAPDH gene, THOC4 gene and SLC33A1 gene. The related lipids are stearidonic acid, Fatty Acids, Total cholesterol, Lipopolysaccharides and Dietary Fatty Acid. The related experimental models are Mouse Model, Transgenic Model, Animal Disease Models and Arthritis, Experimental.
Cross Reference
Introduction
To understand associated biological information of DHA, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with DHA?
DHA is suspected in Cardiovascular Diseases, Obesity, Ischemia, Hypertensive disease, Coronary Arteriosclerosis, Cerebrovascular accident and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with DHA
PubChem Associated disorders and diseases
What pathways are associated with DHA
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with DHA?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
What functions are associated with DHA?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with DHA?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
What genes are associated with DHA?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with DHA?
Mouse Model
Mouse Model are used in the study 'Homeostatic regulation of photoreceptor cell integrity: significance of the potent mediator neuroprotectin D1 biosynthesized from docosahexaenoic acid: the Proctor Lecture.' (Bazan NG, 2007), Mouse Model are used in the study 'Omega-3 fatty acids EPA and DHA: health benefits throughout life.' (Swanson D et al., 2012), Mouse Model are used in the study 'Docosahexaenoic acid attenuates hepatic inflammation, oxidative stress, and fibrosis without decreasing hepatosteatosis in a Ldlr(-/-) mouse model of western diet-induced nonalcoholic steatohepatitis.' (Depner CM et al., 2013) and Mouse Model are used in the study 'Wax esters from the marine copepod Calanus finmarchicus reduce diet-induced obesity and obesity-related metabolic disorders in mice.' (Höper AC et al., 2014).
Transgenic Model
Transgenic Model are used in the study 'Loss of MAP function leads to hippocampal synapse loss and deficits in the Morris Water Maze with aging.' (Ma QL et al., 2014).
Animal Disease Models
Animal Disease Models are used in the study 'Fish oil increases muscle protein mass and modulates Akt/FOXO, TLR4, and NOD signaling in weanling piglets after lipopolysaccharide challenge.' (Liu Y et al., 2013).
Related references are published most in these journals:
| Model | Cross reference | Weighted score | Related literatures |
|---|
NCBI Entrez Crosslinks
All references with DHA
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Nury T et al. | 7-Ketocholesterol is increased in the plasma of X-ALD patients and induces peroxisomal modifications in microglial cells: Potential roles of 7-ketocholesterol in the pathophysiology of X-ALD. | 2017 | J. Steroid Biochem. Mol. Biol. | pmid:27041118 |
| pmid:27041244 | ||||
| pmid:27041321 | ||||
| pmid:27041691 | ||||
| pmid:27044027 | ||||
| pmid:27044314 | ||||
| pmid:27044510 | ||||
| pmid:27044662 | ||||
| pmid:27051354 | ||||
| pmid:27052441 | ||||
| pmid:27056340 | ||||
| Benabdoune H et al. | The role of resolvin D1 in the regulation of inflammatory and catabolic mediators in osteoarthritis. | 2016 | Inflamm. Res. | pmid:27056390 |
| pmid:27058043 | ||||
| pmid:27058527 | ||||
| pmid:27062407 | ||||
| Wang CS et al. | ALX/FPR2 Modulates Anti-Inflammatory Responses in Mouse Submandibular Gland. | 2016 | Sci Rep | pmid:27064029 |
| pmid:27065243 | ||||
| pmid:27065260 | ||||
| pmid:27069145 | ||||
| pmid:27071510 | ||||
| pmid:27072238 | ||||
| pmid:27077882 | ||||
| pmid:27079734 | ||||
| pmid:27082436 | ||||
| pmid:27084093 | ||||
| pmid:27085899 | ||||
| pmid:27085996 | ||||
| McNamara RK and Welge JA | Meta-analysis of erythrocyte polyunsaturated fatty acid biostatus in bipolar disorder. | 2016 | Bipolar Disord | pmid:27087497 |
| pmid:27098595 | ||||
| Zhao YL et al. | Resolvin D1 Protects Lipopolysaccharide-induced Acute Kidney Injury by Down-regulating Nuclear Factor-kappa B Signal and Inhibiting Apoptosis. | 2016 | Chin. Med. J. | pmid:27098797 |
| pmid:27101763 | ||||
| pmid:27102911 | ||||
| pmid:27103520 | ||||
| pmid:27103682 | ||||
| pmid:27105870 | ||||
| pmid:27106721 | ||||
| pmid:27108109 | ||||
| pmid:27116638 | ||||
| pmid:27117144 | ||||
| pmid:27119640 | ||||
| pmid:27121596 | ||||
| pmid:27126710 | ||||
| pmid:27133431 | ||||
| pmid:27134205 | ||||
| pmid:27135386 | ||||
| Fialkow J | Omega-3 Fatty Acid Formulations in Cardiovascular Disease: Dietary Supplements are Not Substitutes for Prescription Products. | 2016 | Am J Cardiovasc Drugs | pmid:27138439 |
| pmid:27138971 | ||||
| pmid:27139422 | ||||
| pmid:27140232 | ||||
| pmid:27142302 | ||||
| Snodgrass RG et al. | Docosahexaenoic acid and palmitic acid reciprocally modulate monocyte activation in part through endoplasmic reticulum stress. | 2016 | J. Nutr. Biochem. | pmid:27142735 |
| Zhao Q et al. | Resolvin D1 Alleviates the Lung Ischemia Reperfusion Injury via Complement, Immunoglobulin, TLR4, and Inflammatory Factors in Rats. | 2016 | Inflammation | pmid:27145782 |
| pmid:27146840 | ||||
| pmid:27151222 | ||||
| pmid:27154359 | ||||
| pmid:27154361 | ||||
| pmid:27154362 | ||||
| Hanssens L et al. | The clinical benefits of long-term supplementation with omega-3 fatty acids in cystic fibrosis patients - A pilot study. | 2016 | Prostaglandins Leukot. Essent. Fatty Acids | pmid:27154364 |
| pmid:27154521 | ||||
| pmid:27157519 | ||||
| pmid:27159788 | ||||
| pmid:27166928 | ||||
| pmid:27167127 | ||||
| McManus S et al. | Differential effects of EPA versus DHA on postprandial vascular function and the plasma oxylipin profile in men. | 2016 | J. Lipid Res. | pmid:27170732 |
| Si TL et al. | Enhanced anti-inflammatory effects of DHA and quercetin in lipopolysaccharide-induced RAW264.7 macrophages by inhibiting NF-κB and MAPK activation. | 2016 | Mol Med Rep | pmid:27176922 |
| Subbaiah PV et al. | Enhanced incorporation of dietary DHA into lymph phospholipids by altering its molecular carrier. | 2016 | Biochim. Biophys. Acta | pmid:27178174 |
| pmid:27181335 | ||||
| Pilley G | Fish oil controversy. | 1989 | DICP | pmid:2718495 |
| pmid:27187161 | ||||
| pmid:27187420 | ||||
| pmid:27188814 | ||||
| pmid:27189059 | ||||
| pmid:27213448 | ||||
| pmid:27216485 | ||||
| pmid:27217152 | ||||
| pmid:27220286 | ||||
| pmid:27225316 | ||||
| Dagorn F et al. | Exploitable Lipids and Fatty Acids in the Invasive Oyster Crassostrea gigas on the French Atlantic Coast. | 2016 | Mar Drugs | pmid:27231919 |
| pmid:27235666 | ||||
| pmid:27235715 | ||||
| pmid:27239420 | ||||
| Pinçon A et al. | Human apolipoprotein E allele and docosahexaenoic acid intake modulate peripheral cholesterol homeostasis in mice. | 2016 | J. Nutr. Biochem. | pmid:27239755 |
| pmid:27248050 | ||||
| pmid:27250120 | ||||
| pmid:27250850 | ||||
| pmid:27255152 | ||||
| pmid:27255641 | ||||
| Croasdell A et al. | Resolvin D2 decreases TLR4 expression to mediate resolution in human monocytes. | 2016 | FASEB J. | pmid:27256622 |
| pmid:27258290 | ||||
| pmid:27258728 | ||||
| pmid:27262097 | ||||
| Metherel AH et al. | Whole-body DHA synthesis-secretion kinetics from plasma eicosapentaenoic acid and alpha-linolenic acid in the free-living rat. | 2016 | Biochim. Biophys. Acta | pmid:27263420 |
| pmid:27269707 | ||||
| pmid:27269711 | ||||
| Gramer G et al. | Long-chain polyunsaturated fatty acid status in children, adolescents and adults with phenylketonuria. | 2016 | Prostaglandins Leukot. Essent. Fatty Acids | pmid:27269713 |
| pmid:27276431 | ||||
| pmid:27279274 | ||||
| Allaire J et al. | A randomized, crossover, head-to-head comparison of eicosapentaenoic acid and docosahexaenoic acid supplementation to reduce inflammation markers in men and women: the Comparing EPA to DHA (ComparED) Study. | 2016 | Am. J. Clin. Nutr. | pmid:27281302 |
| Jeyanathan J et al. | Biohydrogenation of 22:6n-3 by Butyrivibrio proteoclasticus P18. | 2016 | BMC Microbiol. | pmid:27283157 |
| pmid:27287561 |